Hextar Healthcare Berhad Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Chin Khoo

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	11.3yrs
Eigendom CEO	0.005%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	2.5yrs

Recente managementupdates

Recent updates

Unpleasant Surprises Could Be In Store For Hextar Healthcare Berhad's (KLSE:HEXCARE) Shares

Nov 06

Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking

Dec 18

The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing

Aug 30

We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger

May 27

Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)

Feb 26

Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?

Nov 17

If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late

May 11

What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?

Apr 12

Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 02

Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today

Feb 09

Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive

Jan 22

How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?

Jan 04

If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today

Dec 17

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?

Dec 02

Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?

Nov 18

What Does Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) CEO Pay Reveal?

Jul 14

Analyse CEO-vergoeding

Hoe is Chin Khoo's beloning veranderd ten opzichte van Hextar Healthcare Berhad's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-RM 52m
Jun 30 2024	n/a	n/a	-RM 58m
Mar 31 2024	n/a	n/a	-RM 61m
Dec 31 2023	n/a	n/a	-RM 64m
Sep 30 2023	n/a	n/a	-RM 74m
Jun 30 2023	n/a	n/a	-RM 69m
Mar 31 2023	n/a	n/a	-RM 61m
Dec 31 2022	n/a	n/a	-RM 56m
Sep 30 2022	n/a	n/a	RM 10m
Jun 30 2022	n/a	n/a	RM 39m
Mar 31 2022	n/a	n/a	RM 102m
Dec 31 2021	RM 1m	RM 1m	RM 186m
Sep 30 2021	n/a	n/a	RM 236m
Jun 30 2021	n/a	n/a	RM 250m
Mar 31 2021	n/a	n/a	RM 208m
Dec 31 2020	RM 1m	RM 1m	RM 131m
Sep 30 2020	n/a	n/a	RM 76m
Jun 30 2020	n/a	n/a	RM 39m
Mar 31 2020	n/a	n/a	RM 19m
Dec 31 2019	RM 943k	RM 943k	RM 11m
Sep 30 2019	n/a	n/a	RM 11m
Jun 30 2019	n/a	n/a	RM 10m
Mar 31 2019	n/a	n/a	RM 10m
Dec 31 2018	RM 613k	RM 613k	RM 9m
Sep 30 2018	n/a	n/a	RM 7m
Jun 30 2018	n/a	n/a	RM 7m
Mar 31 2018	n/a	n/a	RM 8m
Dec 31 2017	RM 642k	RM 642k	RM 10m

Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Chin redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de MY markt.

Compensatie versus inkomsten: De vergoeding van Chin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Chin Khoo (65 yo)

11.3yrs

Tenure

Mr. Chin Leng Khoo has been Group Managing Director and Director of Hextar Healthcare Berhad (formerly known as Rubberex Corporation (M) Berhad) since July 1, 2013 and served as its Financial Manager. Mr....

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Chin Khoo	Group MD & Director	11.3yrs	geen gegevens	0.0050% MYR 9.6k
Hsu-Ming Goh	Non-Independent Executive Director	3.3yrs	geen gegevens	geen gegevens
Yee Fuan Sim	Independent Non-Executive Director	1.5yrs	RM 34.00k	geen gegevens
Jee Min Liew	Independent & Non Executive Chairman	3.3yrs	RM 66.00k	geen gegevens
Siew Lim	Independent Non-Executive Director	1.8yrs	RM 55.00k	geen gegevens
Chin Cheng	Independent Non-Executive Director	1.8yrs	RM 57.00k	geen gegevens

2.5yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van HEXCARE wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.5 jaar), wat duidt op een nieuw bestuur.

Hextar Healthcare Berhad Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Hextar Healthcare Berhad Announces Change of Company Secretary

Hextar Healthcare Berhad, Annual General Meeting, May 27, 2024

Hextar Healthcare Berhad Announces the Resignation of Lim Chee Lip, as Executive Director

Hextar Healthcare Berhad Appoints Mastura Binti Muhamad as Company Secretary

Hextar Healthcare Berhad Announces Appointment of Sim Yee Fuan as Independent and Non Executive Member of Nomination and Remuneration Committee

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: RM0.004 loss per share (vs RM0.01 loss in 3Q 2023)

New minor risk - Share price stability

Unpleasant Surprises Could Be In Store For Hextar Healthcare Berhad's (KLSE:HEXCARE) Shares

Hextar Healthcare Berhad Announces Change of Company Secretary

Second quarter 2024 earnings released: RM0.002 loss per share (vs RM0.006 loss in 2Q 2023)

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: RM0.001 (vs RM0.003 loss in 1Q 2023)

Hextar Healthcare Berhad, Annual General Meeting, May 27, 2024

Full year 2023 earnings released: RM0.066 loss per share (vs RM0.062 loss in FY 2022)

New major risk - Share price stability

Hextar Healthcare Berhad Announces the Resignation of Lim Chee Lip, as Executive Director

Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking

Third quarter 2023 earnings released: RM0.01 loss per share (vs RM0.005 loss in 3Q 2022)

New minor risk - Share price stability

Hextar Healthcare Berhad Appoints Mastura Binti Muhamad as Company Secretary

Second quarter 2023 earnings released: RM0.006 loss per share (vs RM0.002 profit in 2Q 2022)

First quarter 2023 earnings released: RM0.003 loss per share (vs RM0.003 profit in 1Q 2022)

Hextar Healthcare Berhad Announces Appointment of Sim Yee Fuan as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.063 loss per share (vs RM0.22 profit in FY 2021)

High number of new and inexperienced directors

Hextar Healthcare Berhad Appoints Lim Siew Eng as Independent and Non Executive Member of Nomination and Remuneration Committee, Effective from January 1, 2023

Hextar Healthcare Berhad Announces Appointment of Wong Yee Leng as Company Secretary

Third quarter 2022 earnings released: RM0.005 loss per share (vs RM0.03 profit in 3Q 2021)

High number of new directors

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) completed the acquisition of Reszon Diagnostics International Sdn. Bhd. from Revongen Corporation Sdn Bhd and Law Eng Lim.

The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing

Second quarter 2022 earnings released: EPS: RM0.002 (vs RM0.078 in 2Q 2021)

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) agreed to acquire Reszon Diagnostics International Sdn. Bhd. from Revongen Corporation Sdn Bhd and Law Eng Lim for RMB 180 million.

We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger

Full year 2021 earnings: EPS and revenues miss analyst expectations

High number of new directors

Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Rubberex Corporation (M) Berhad Announces Redesignation of Mohamed Bin Hamzah from Member of Nomination Committee to Chairman of Nomination Committee

Third quarter 2021 earnings: EPS and revenues miss analyst expectations

Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?

Independent Non Executive Director Mustapha Bin Mohamed has left the company

High number of new directors

Second quarter 2021 earnings released: EPS RM0.078 (vs RM0.028 in 2Q 2020)

Director Jee Liew has joined 5th company board

First quarter 2021 earnings released: EPS RM0.10 (vs RM0.012 in 1Q 2020)

If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS RM0.16 (vs RM0.015 in FY 2019)

What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?

Investor sentiment improved over the past week

Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS RM0.16 (vs RM0.015 in FY 2019)

New 90-day low: RM1.30

Investor sentiment deteriorated over the past week

Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today

Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive

Investor sentiment improved over the past week

How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?

New 90-day low: RM1.35

If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today

New 90-day low: RM1.54

Market pulls back on stock over the past week

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?

Third quarter 2020 earnings released: EPS RM0.05

Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?

Market pulls back on stock over the past week

Rubberex Corporation (M) Berhadd Announces the Appointment of Chan Choun Sien, Independent and Non Executive as Member of Remuneration Committee

Market bids up stock over the past week

Market pulls back on stock over the past week

New 90-day high: RM7.40

First half earnings released

Erpstar Inc. Sdn. Bhd. completed the offer to acquire an additional 0.96% stake in Rubberex Corporation (M) Berhad (KLSE:RUBEREX) for approximately MYR 4.8 million.